Home » Topics » BioWorld Science

BioWorld Science
RSS

CtBP2 affects multiple pathways in acute kidney injury

Nov. 22, 2019

First-in-human trial with the triple gene construct INXN-4001 for treatment of heart failure

Nov. 22, 2019

Phase II data on AG-10 in ATTR cardiomyopathy support entry into phase III

Nov. 22, 2019

ALG-055009: a THR-beta agonist for treating NASH

Nov. 22, 2019

Positive preclinical data reported for leronlimab in humanized mouse model of NAFLD

Nov. 22, 2019

Pfizer initiates first-in-human study of PF-07038124

Nov. 22, 2019

First-in-human study of AZD-2693

Nov. 22, 2019

FDA clears IND application for phase I study of BP-1002

Nov. 22, 2019

European Commission approves Rhokiinsa

Nov. 22, 2019

Osteoclast precursor macrophages are potential RA therapeutic targets

Nov. 22, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...